HUP0204467A2 - Propinoil-l-karnitin és koenzim Q10-et tartalmazó készítmény érrendszeri betegségek megelőzésére és/vagy kezelésére - Google Patents

Propinoil-l-karnitin és koenzim Q10-et tartalmazó készítmény érrendszeri betegségek megelőzésére és/vagy kezelésére

Info

Publication number
HUP0204467A2
HUP0204467A2 HU0204467A HUP0204467A HUP0204467A2 HU P0204467 A2 HUP0204467 A2 HU P0204467A2 HU 0204467 A HU0204467 A HU 0204467A HU P0204467 A HUP0204467 A HU P0204467A HU P0204467 A2 HUP0204467 A2 HU P0204467A2
Authority
HU
Hungary
Prior art keywords
prevention
carnitine
coenzyme
propionyl
treatment
Prior art date
Application number
HU0204467A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of HUP0204467A2 publication Critical patent/HUP0204467A2/hu
Publication of HUP0204467A3 publication Critical patent/HUP0204467A3/hu
Publication of HU229421B1 publication Critical patent/HU229421B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya vaszkulopátiás, szív-, központi és periferiálisagyi zavarok megelőzésére és/vagy kezelésére, valamint tanulásirendellenességek vagy öregedéssel kapcsolatos rendellenességekmegelőzésére alkalmas készítmény, amely létezhet táplálékkiegészítővagy valódi gyógyszer formájában és jellemző összetevőként azalábbiakat tartalmazza: (a) propionil-L-karnitin vagy gyógyászatilagelfogadható sója, és (b) koenzim Q10. Ó
HU0204467A 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 HU229421B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000106A IT1316997B1 (it) 2000-03-02 2000-03-02 Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
PCT/IT2001/000081 WO2001064203A2 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q¿10?

Publications (3)

Publication Number Publication Date
HUP0204467A2 true HUP0204467A2 (hu) 2003-06-28
HUP0204467A3 HUP0204467A3 (en) 2006-07-28
HU229421B1 HU229421B1 (en) 2013-12-30

Family

ID=11454491

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204467A HU229421B1 (en) 2000-03-02 2001-02-20 Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10

Country Status (19)

Country Link
US (1) US6814972B2 (hu)
EP (1) EP1263423B1 (hu)
AR (1) AR027958A1 (hu)
AT (1) ATE335473T1 (hu)
AU (2) AU4103001A (hu)
CA (1) CA2400959C (hu)
CY (1) CY1106168T1 (hu)
CZ (1) CZ20022758A3 (hu)
DE (1) DE60122114T2 (hu)
DK (1) DK1263423T3 (hu)
ES (1) ES2269355T3 (hu)
HU (1) HU229421B1 (hu)
IT (1) IT1316997B1 (hu)
MX (1) MXPA02008532A (hu)
PL (1) PL207536B1 (hu)
PT (1) PT1263423E (hu)
SK (1) SK12402002A3 (hu)
TN (1) TNSN01033A1 (hu)
WO (1) WO2001064203A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002309038B2 (en) * 2001-05-10 2007-05-17 Kaneka Corporation Compositions for transmucosal administration containing coenzyme Q as the active ingredient
TW200304373A (en) * 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Percutaneous absorption promoters and compositions for treating athlete's foot
WO2010127297A1 (en) 2009-05-01 2010-11-04 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
EP2582368B1 (en) * 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6232346B1 (en) * 1997-03-27 2001-05-15 Michael J. Sole Composition for improvement of cellular nutrition and mitochondrial energetics
ES2201467T3 (es) 1997-03-27 2004-03-16 Michael J. Sole Composicion nutritiva para la mejora energetica de la celula.
IT1299197B1 (it) * 1998-06-30 2000-02-29 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante, antiproliferativa, energetica e atta a migliorare l'utilizzazione metabolica del glucosio.
IT1306130B1 (it) * 1999-04-16 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti.
IT1306133B1 (it) * 1999-04-22 2001-05-30 Sigma Tau Healthscience Spa Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
IT1317008B1 (it) 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.

Also Published As

Publication number Publication date
CZ20022758A3 (cs) 2003-02-12
EP1263423B1 (en) 2006-08-09
ITRM20000106A0 (it) 2000-03-02
HUP0204467A3 (en) 2006-07-28
PL207536B1 (pl) 2010-12-31
AU4103001A (en) 2001-09-12
ITRM20000106A1 (it) 2001-09-02
US6814972B2 (en) 2004-11-09
SK12402002A3 (sk) 2003-02-04
HU229421B1 (en) 2013-12-30
DE60122114D1 (de) 2006-09-21
ATE335473T1 (de) 2006-09-15
WO2001064203A2 (en) 2001-09-07
AR027958A1 (es) 2003-04-16
TNSN01033A1 (fr) 2005-11-10
WO2001064203A3 (en) 2002-03-28
CY1106168T1 (el) 2011-06-08
CA2400959C (en) 2011-01-04
PL358178A1 (en) 2004-08-09
AU2001241030B8 (en) 2005-10-20
AU2001241030B2 (en) 2005-09-15
DE60122114T2 (de) 2007-02-08
IT1316997B1 (it) 2003-05-26
EP1263423A2 (en) 2002-12-11
PT1263423E (pt) 2006-11-30
ES2269355T3 (es) 2007-04-01
CA2400959A1 (en) 2001-09-07
DK1263423T3 (da) 2006-12-11
MXPA02008532A (es) 2003-02-12
US20030059418A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
WO2005110375A8 (en) Nutritional supplement for treatment of ocular diseases
HUP0102909A2 (hu) L-karnitint és alfa-liponsavat tartalmazó antioxidáns készítmény
CA2449892A1 (en) Nutritional supplement to treat macular degeneration
CA2458067A1 (en) Use of flibanserin in the treatment of sexual disorders
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
TW200612903A (en) Use of trisubstituted benzopyranones
HUP0400589A2 (hu) Kolosztrumalapú készítmény
GR20020100506A (el) Φαρμακευτικη συνθεση
HUP0102501A2 (hu) Karnitint és glutationt tartalmazó, a glutation abszorpcióját fokozó és hatását erősítő készítmény
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
HUP0203449A2 (hu) L-karnitin-számazékokat és ginkgo biloba kivonatot tartalmazó készítmény keringési rendellenességek megelőzésére és/vagy kezelésére
CA2412789A1 (en) Compositions for improving mental concentration
HUP0102926A2 (hu) Karnitint és inozit-foszfátot tartalmazó, táplálékkiegészítőként vagy gyógyszerként alkalmazható készítmény
HK1118722A1 (en) Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
HUP0102807A2 (hu) Karnitint és karotenoidet tartalmazó antioxidáns, antiproliferációs készítmény
IT1295408B1 (it) Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
HUP0204467A2 (hu) Propinoil-l-karnitin és koenzim Q10-et tartalmazó készítmény érrendszeri betegségek megelőzésére és/vagy kezelésére
RU2004114844A (ru) Применение цистатионина
AU2010206791B2 (en) A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
EP1393738A4 (en) MEDICINE AGAINST DIABETES
HUP0202119A2 (hu) OCIF-ot és poliszacharidot tartalmazó komplex
HUP0203379A2 (hu) Propionil-L-karnitint és kitozánt tartalmazó készítmény abnormális lipidmetabolizmusból eredő rendellenességek megelőzésére és/vagy kezelésére
CN109223642A (zh) 一种除垢除臭调理漱口水
DE60326262D1 (de) Verwendung von carnitinen zur prävention und/oder behandlung von krankheiten die durch die andropause verursacht werden

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: SIGMA-TAU INDUSTRIE PHARMACEUTICHE RIUNITE S.P, IT

Free format text: FORMER OWNER(S): SIGMA-TAU HEALTHSCIENCE S.P.A., IT

MM4A Lapse of definitive patent protection due to non-payment of fees